Literature DB >> 3262128

Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.

M A Brown1, D W Myears, S R Bergmann.   

Abstract

Noninvasive quantification of regional myocardial metabolism would be highly desirable to evaluate pathogenetic mechanisms of heart disease and their response to therapy. It was previously demonstrated that the metabolism of radiolabeled acetate, a readily utilized myocardial substrate predominantly metabolized to carbon dioxide (CO2) by way of the tricarboxylic acid cycle, provides a good index of oxidative metabolism in isolated perfused rabbit hearts because of tight coupling between the tricarboxylic acid cycle and oxidative phosphorylation. In the present study, in a prelude to human studies, the relation between myocardial clearance of carbon-11 (11C)-labeled acetate and myocardial oxygen consumption was characterized in eight intact dogs using positron emission tomography. Anesthetized dogs were studied during baseline conditions and again during either high or low work states induced pharmacologically. High myocardial extraction and rapid blood clearance of tracer yielded myocardial images of excellent quality. The turnover (clearance) of 11C radioactivity from the myocardium was biexponential with the mean half-time of the dominant rapid phase averaging 5.4 +/- 2.2, 2.8 +/- 1.3 and 11.1 +/- 1.3 min in control, high and low work load studies, respectively. No significant difference was found between the rate of clearance of 11C radioactivity from the myocardium measured noninvasively with positron emission tomography and the myocardial efflux of 11CO2 measured directly from the coronary sinus. The rate of clearance of the 11C radioactivity from the heart correlated closely with myocardial oxygen consumption (r = 0.90, p less than 0.001) as well as with the rate-pressure product (r = 0.95, p less than 0.001). Hence, the rate of oxidation of 11C-acetate can be determined noninvasively with positron emission tomography, providing a quantitative index of oxidative metabolism under diverse conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262128     DOI: 10.1016/0735-1097(88)90476-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Use of carbon 11-acetate for the measurement of myocardial oxygen consumption.

Authors:  O Akinboboye; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  [11C]Acetate rest-stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats.

Authors:  Etienne Croteau; Suzanne Gascon; M'hamed Bentourkia; Réjean Langlois; Jacques A Rousseau; Roger Lecomte; François Bénard
Journal:  Nucl Med Biol       Date:  2011-11-12       Impact factor: 2.408

3.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

Review 4.  Positron emission tomography in acute coronary syndromes.

Authors:  Leonarda Galiuto; Lazzaro Paraggio; Alberto R De Caterina; Elisa Fedele; Gabriella Locorotondo; Lucia Leccisotti; Alessandro Giordano; Antonio G Rebuzzi; Filippo Crea
Journal:  J Cardiovasc Transl Res       Date:  2011-12-15       Impact factor: 4.132

Review 5.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 6.  Imaging of myocardial fatty acid metabolism with PET.

Authors:  Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 7.  Mathematical modelling in nuclear medicine.

Authors:  J T Kuikka; J B Bassingthwaighte; M M Henrich; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1991

8.  Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling.

Authors:  Nobuyuki Ohte; Hitomi Narita; Akihiko Iida; Kazuaki Wakami; Kaoru Asada; Hidekatsu Fukuta; Takafumi Kato; Junichiro Hyano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

9.  Quantitative analysis of 99mTc-HMPAO kinetics in epilepsy.

Authors:  J T Kuikka; E Länsimies; E O Kuikka
Journal:  Eur J Nucl Med       Date:  1990

10.  Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart.

Authors:  M E Jessen; T E Kovarik; F M Jeffrey; A D Sherry; C J Storey; R Y Chao; W S Ring; C R Malloy
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.